The medical cannabis industry came into existence in 2018 in Denmark. While still a relatively emerging industry, the past half a decade has created an extended ecosystem around the production of medical cannabis that shapes the competitiveness of the industry and determines the path forward.
Supporting industries, key stakeholders, and potential partners ensure strong growth for the sector, including plant sciences and technology, new approaches to cultivation, product development, and most importantly clinical evidence that contributes to the ultimate end-users: patients and their doctors.
Companies in the industry cannot compete effectively without these vital pieces in place. It is up to the industry to engage with these partners to ensure continued development of the sector.
What’s next for the medical cannabis industry?
The trial program for the production of medical cannabis has ended, replaced by a permanent framework for production, manufacture, and export. This signals a shift in focus, from getting established and launching the first products on the market, towards a greater need for long-term drivers of success such as efficiency, sustainability, and impact.
Meanwhile, the ability for doctors to prescribe medical cannabis as part of a pilot scheme has been extended for an additional four years, with an assessment scheduled for the end of 2024. Evidence generated in the current pilot program will determine the shape of the industry going forward.
This is the theme of this year’s event: The next step. Discussion will include new knowledge and sharing experiences of international contexts for removing bottlenecks for plant production, product development, and engagement with doctors and patients.
The Symposium
The Medical Cannabis Symposium functions as a platform for knowledge exchange between experts along the value chain from “Plant to Patient”. This is the 4th edition of the Symposium, and aims to engage with stakeholders as the industry matures into its next phase of development.
The Symposium is based on understanding the value chain “From Plant to Patient” and involves creating links between the various stakeholders that are involved in this dynamic industry.
The detailed program will follow when the date of the symposium approaches.
- Session 1: Plant breeding: Applying breeding tactics for the medical cannabis industry
- Session 2: Plant cultivation: Cultivation technologies to support sustainability
- Session 3: Product development: Engagement with the wider ecosystem
- Session 4: Clinical studies: Research on new applications
- Session 5: Patient application: The Nordic perspective on research collaboration
- Networking at Storms Pakhus afterwards!
About the hosts
Invest in Denmark – National investment promotion agency under the Ministry of Foreign Affairs, Invest in Denmark has been actively involved in attracting medical cannabis investments into the Danish ecosystem, generating jobs and economic growth across Denmark.
Invest in Odense helps promote the local and national medical cannabis industry, and hosts network events. Invest in Odense is part of Odense Municipality and part of the triple helix collaboration connecting companies, science and government to develop the industry and generate growth.
Danish Technological Institute (GTS) transferring science to industry. For more than 112 years the Institute is supporting the Danish industry with new technology and innovations. Center for Bioressourcer working on optimized plants production indoor and in tissue culture as well as conducting breeding methods as using side streams for circular production.
